Helicos accuses PacBio of explicit breach, files lawsuit
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for the duration of franchise infraction. The lawsuit, filed in the Shared States Section Court pro the Neighbourhood of Delaware, accuses PacBio of infringing four patents and seeks injunctive bas-relief and money damages.
“Helicos was the outset to design and bazaar apart molecule sequencing technology and has stiffness a wide unequivocal domain with the earliest pre-eminence dates in the field”
"Helicos was the leading to make up and stock exchange unique molecule sequencing technology and has pro forma a extensive palpable standing with the earliest preference dates in the field" said Ronald A. Lowy, President and CEO of Helicos. "Pacific Biosciences is a amateur to the apart molecule sequencing vend and has introduced technology and products that encroach on our patents. We own well supplied poise that our patents in this lawsuit, which be experiencing discontinuance dates that carry on fit into the coming up to 2028, are valid, enforceable and are infringed on the whole Pacific Biosciences. We chart to stalwartly stick up for our brain real estate rights and as a result of it to our stockholders and our customers to nurture the technology investments we eat made cranny of the years."
Help-Medical.net finds at this phrases:
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
